Uterine Fibroids (UF)
11
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief
HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety
Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization
Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus
A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
POPQ Associated With Total Laparoscopic Hysterectomy
Comparative Effects of Kegel Versus Clamshell Exercises on Low Back Pain in Women With Uterine Fibroids: A Randomized Clinical Trial
Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease
Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation